IP Verse

Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna

Patent No. EP3981427 (titled "Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna") was filed by Glaxosmithkline on Aug 31, 2011. The application was issued on Jul 27, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JG OPPOSITIONSFeb 27, 2023MEWBURN ELLIS
MARGARET DIXONFeb 24, 2023MEWBURN ELLIS
WEICKMANN & WEICKMANNFeb 23, 2023-
SANOFIFeb 21, 2023ELKINGTON AND FIFE
THOMANNFeb 21, 2023-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3981427

GLAXOSMITHKLINE
Application Number
EP21205422A
Filing Date
Aug 31, 2011
Status
Revoked
Jan 24, 2025
Publication Date
Jul 27, 2022
External Links
Slate, Register , Google Patents